These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32758192)

  • 1. Comparison of visual field progression in new-diagnosed primary open-angle and exfoliation glaucoma patients in Sweden.
    Ayala M
    BMC Ophthalmol; 2020 Aug; 20(1):322. PubMed ID: 32758192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for visual field progression in newly diagnosed exfoliation glaucoma patients in Sweden.
    Ayala M
    Sci Rep; 2022 Jun; 12(1):10763. PubMed ID: 35750795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors and Frequency of Examinations for Detecting Visual Field Deterioration in Patients with Newly Diagnosed Exfoliation Glaucoma in Sweden.
    Ayala M
    J Glaucoma; 2024 Mar; 33(3):168-175. PubMed ID: 37853670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating functions for visual field progression in newly diagnosed exfoliation glaucoma patients in Sweden.
    Ayala M
    Sci Rep; 2023 Nov; 13(1):20979. PubMed ID: 38017090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of visual field progression in clinical glaucoma care.
    Heijl A; Buchholz P; Norrgren G; Bengtsson B
    Acta Ophthalmol; 2013 Aug; 91(5):406-12. PubMed ID: 23066646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threat to fixation at diagnosis and lifetime risk of visual impairment in open-angle glaucoma.
    Peters D; Bengtsson B; Heijl A
    Ophthalmology; 2015 May; 122(5):1034-9. PubMed ID: 25537196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Former smoking as a risk factor for visual field progression in exfoliation glaucoma patients in Sweden.
    Ayala M
    Eur J Ophthalmol; 2024 Jan; ():11206721241226990. PubMed ID: 38233361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population.
    Casas-Llera P; Rebolleda G; Muñoz-Negrete FJ; Arnalich-Montiel F; Pérez-López M; Fernández-Buenaga R
    Br J Ophthalmol; 2009 Dec; 93(12):1576-9. PubMed ID: 19535357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucoma progression detection: agreement, sensitivity, and specificity of expert visual field evaluation, event analysis, and trend analysis.
    Antón A; Pazos M; Martín B; Navero JM; Ayala ME; Castany M; Martínez P; Bardavío J
    Eur J Ophthalmol; 2013; 23(2):187-95. PubMed ID: 23065852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial.
    Yokoyama Y; Kawasaki R; Takahashi H; Maekawa S; Tsuda S; Omodaka K; Nakazawa T
    J Glaucoma; 2019 Jul; 28(7):575-583. PubMed ID: 31188229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchical cluster analysis of progression patterns in open-angle glaucoma patients with medical treatment.
    Bae HW; Rho S; Lee HS; Lee N; Hong S; Seong GJ; Sung KR; Kim CY
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3231-6. PubMed ID: 24781944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia.
    Yoshino T; Fukuchi T; Togano T; Sakaue Y; Seki M; Tanaka T; Ueda J
    Jpn J Ophthalmol; 2016 Mar; 60(2):78-85. PubMed ID: 26822678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHORT TERM EVALUATION OF PERIMETRIC PROGRESSION IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND DIABETES.
    Pantalon A; Feraru C; Chiseliţa D
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):83-9. PubMed ID: 27125077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Fast Visual Field Progression in Glaucoma.
    Kim JH; Rabiolo A; Morales E; Yu F; Afifi AA; Nouri-Mahdavi K; Caprioli J
    Am J Ophthalmol; 2019 Nov; 207():268-278. PubMed ID: 31238025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of glaucoma patients identified through mass screening and in routine clinical practice.
    Grødum K; Heijl A; Bengtsson B
    Acta Ophthalmol Scand; 2002 Dec; 80(6):627-31. PubMed ID: 12485284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series.
    Bleisch D; Furrer S; Funk J
    BMC Ophthalmol; 2015 Dec; 15():179. PubMed ID: 26667206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with lifetime risk of open-angle glaucoma blindness.
    Peters D; Bengtsson B; Heijl A
    Acta Ophthalmol; 2014 Aug; 92(5):421-5. PubMed ID: 23837818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between visual field defect in pigmentary glaucoma and primary open-angle glaucoma.
    Nilforushan N; Yadgari M; Jazayeri A
    Int Ophthalmol; 2016 Oct; 36(5):637-42. PubMed ID: 26758071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.